SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Larkina Maria)
 

Sökning: WFRF:(Larkina Maria) > (2023) > Synthesis, I-123-Ra...

  • Hasnowo, Lutfi A.Tomsk Polytech Univ, Sch Nucl Sci & Engn, Tomsk 634050, Russia.;Natl Res & Innovat Agcy, Polytech Inst Nucl Technol, Yogyakarta 55281, Indonesia. (författare)

Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • MDPI,2023
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-510103
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-510103URI
  • https://doi.org/10.3390/ijms241512206DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Prostate-specific membrane antigen (PSMA) has been identified as a target for the development of theranostic agents. In our current work, we describe the design and synthesis of novel N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-(S)-L-lysine (DCL) urea-based PSMA inhibitors with a chlorine-substituted aromatic fragment at the lysine & epsilon;-nitrogen atom, a dipeptide including two phenylalanine residues in the L-configuration as the peptide fragment of the linker, and 3- or 4-(tributylstannyl)benzoic acid as a prosthetic group in their structures for radiolabeling. The standard compounds [I-127]PSMA-m-IB and [I-127]PSMA-p-IB for comparative and characterization studies were first synthesized using two alternative synthetic approaches. An important advantage of the alternative synthetic approach, in which the prosthetic group (NHS-activated esters of compounds) is first conjugated with the polypeptide sequence followed by replacement of the Sn(Bu)(3) group with radioiodine, is that the radionuclide is introduced in the final step of synthesis, thereby minimizing operating time with iodine-123 during the radiolabeling process. The obtained DCL urea-based PSMA inhibitors were radiolabeled with iodine-123. The radiolabeling optimization results showed that the radiochemical yield of [I-123]PSMA-p-IB was higher than that of [I-123]PSMA-m-IB, which were 74.9 & PLUSMN; 1.0% and 49.4 & PLUSMN; 1.2%, respectively. The radiochemical purity of [I-123]PSMA-p-IB after purification was greater than 99.50%. The initial preclinical evaluation of [I-123]PSMA-p-IB demonstrated a considerable affinity and specific binding to PC-3 PIP (PSMA-expressing cells) in vitro. The in vivo biodistribution of this new radioligand [I-123]PSMA-p-IB showed less accumulation than [Lu-177]Lu-PSMA-617 in several normal organs (liver, kidney, and bone). These results warrant further preclinical development, including toxicology evaluation and experiments in tumor-bearing mice.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Larkina, Maria S.Tomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Res Ctr Oncotheranost, Tomsk 634050, Russia.;Siberian State Med Univ, Dept Pharmaceut Anal, Tomsk 634050, Russia. (författare)
  • Plotnikov, EvgeniiTomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Res Ctr Oncotheranost, Tomsk 634050, Russia.;Russian Acad Sci, Mental Hlth Reseach Inst, Tomsk Natl Res Med Ctr, Tomsk 634014, Russia. (författare)
  • Bodenko, VitalinaTomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Res Ctr Oncotheranost, Tomsk 634050, Russia.;Siberian State Med Univ, Dept Pharmaceut Anal, Tomsk 634050, Russia. (författare)
  • Yuldasheva, FeruzaTomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Res Ctr Oncotheranost, Tomsk 634050, Russia. (författare)
  • Stasyuk, ElenaTomsk Polytech Univ, Sch Nucl Sci & Engn, Tomsk 634050, Russia. (författare)
  • Petrov, Stanislav A.Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119991, Russia. (författare)
  • Zyk, Nikolai Y.Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119991, Russia. (författare)
  • Machulkin, Aleksei E.Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119991, Russia. (författare)
  • Vorozhtsov, Nikolai I.Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119991, Russia. (författare)
  • Beloglazkina, Elena K.Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119991, Russia. (författare)
  • Nenajdenko, Valentine G.Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119991, Russia. (författare)
  • Tolmachev, VladimirUppsala universitet,Cancerprecisionsmedicin(Swepub:uu)vladtolm (författare)
  • Orlova, Anna,1960-Uppsala universitet,Theranostics(Swepub:uu)annaorlo (författare)
  • Majouga, Alexander G.Dmitry Mendeleev Univ Chem Technol Russia, Fac Chem, Miusskaya sq 9, Moscow 125047, Russia. (författare)
  • Yusubov, Mekhman S.Tomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Res Ctr Oncotheranost, Tomsk 634050, Russia. (författare)
  • Tomsk Polytech Univ, Sch Nucl Sci & Engn, Tomsk 634050, Russia.;Natl Res & Innovat Agcy, Polytech Inst Nucl Technol, Yogyakarta 55281, Indonesia.Tomsk Polytech Univ, Res Sch Chem & Appl Biomed Sci, Res Ctr Oncotheranost, Tomsk 634050, Russia.;Siberian State Med Univ, Dept Pharmaceut Anal, Tomsk 634050, Russia. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:International Journal of Molecular Sciences: MDPI24:151661-65961422-0067

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy